Most Read Articles
Stephen Padilla, 5 days ago
Use of noninvasive ventilation (NIV), similar to invasive mechanical ventilation (IMV), appears to lessen mortality but may increase the risk for transmission of the novel coronavirus disease (COVID-19) in healthcare workers, suggest the results of a study.
Roshini Claire Anthony, 08 May 2020

At present, there are no definitive treatments for COVID-19. More than 300 clinical trials are ongoing in the search for a cure. Some of the treatments being tested were previously used, with varying levels of efficacy, in the treatment of severe acute respiratory syndrome (SARS) or Middle East respiratory syndrome (MERS).

Pank Jit Sin, 21 May 2020

Persons suffering from asthma should pay particular attention to SARS-CoV-2 precautionary measures such as social distancing, regular handwashing, and wearing of masks on top of keeping their asthma in control. This is because data collected so far paints a bleaker picture for asthmatics than the normal population should they catch COVID-19.

Pank Jit Sin, 21 May 2020
Two new studies have brought into question the widespread use of hydroxychloroquine in COVID-19 patients. One is French in origin while the other is Chinese.

Handheld flow meter improves COPD screening despite questionnaire use

31 Jan 2020

Use of the handheld flow meter (HFM), regardless of using a symptom-based questionnaire, proves beneficial in detecting chronic obstructive pulmonary disease (COPD), a recent study has shown.

The investigators sought to identify the benefit of utilizing an HFM in COPD screening among 2,008 participants aged 40 years from Isumi City, Japan. They developed two novel point systems for detecting COPD: one incorporated score of HFM alone (sHFM) and the other incorporated the score of International Primary Care Airway Group questionnaire (IPAG) and HFM (sIPAG + HFM).

Random sample allocation (split-sample validation) was conducted to validate the predictive performance of these models. To perform the split-sample validation, participants were assigned to either of the following data set: model creation (n=1,007) or model assessment (n=1,001).

In decision curve analysis, sHFM and sIPAG + HFM both had significantly higher net benefit and specificity than that of the sIPAG. However, the curves of sHFM and sIPAG + HFM were crossing and practically the same with no significant difference in sensitivity and specificity.

“This study confirms that HFM is significantly advantageous in detecting COPD despite the use of a conventional questionnaire,” the investigators said.

These findings are consistent with those of a 2011 study, which suggested that using both the IPAG questionnaire and the handheld PiKo-6 spirometer can increase the possibility of an early and accurate diagnosis of COPD in the primary care setting. [Prim Care Respir J 2011;20:184-189]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 5 days ago
Use of noninvasive ventilation (NIV), similar to invasive mechanical ventilation (IMV), appears to lessen mortality but may increase the risk for transmission of the novel coronavirus disease (COVID-19) in healthcare workers, suggest the results of a study.
Roshini Claire Anthony, 08 May 2020

At present, there are no definitive treatments for COVID-19. More than 300 clinical trials are ongoing in the search for a cure. Some of the treatments being tested were previously used, with varying levels of efficacy, in the treatment of severe acute respiratory syndrome (SARS) or Middle East respiratory syndrome (MERS).

Pank Jit Sin, 21 May 2020

Persons suffering from asthma should pay particular attention to SARS-CoV-2 precautionary measures such as social distancing, regular handwashing, and wearing of masks on top of keeping their asthma in control. This is because data collected so far paints a bleaker picture for asthmatics than the normal population should they catch COVID-19.

Pank Jit Sin, 21 May 2020
Two new studies have brought into question the widespread use of hydroxychloroquine in COVID-19 patients. One is French in origin while the other is Chinese.